Biomarkers in blood and saliva to screen fragile patients with solid tumors: A systematic review of the literature
There are currently no established blood or salivary biomarkers for frailty. However, an elevated inflammatory status and related markers are often significantly correlated with frailty in solid tumor patients. These findings highlight the potential to develop suitable biomarkers for frail oncology patients, emphasizing the need for further research in this area.
Authors
- Lorena Cascant Ortolano (ORCID: https://orcid.org/0000-0003-4839-6457)
- Annette Hasenburg (ORCID: https://orcid.org/0000-0002-1547-4968)
- Valerie Catherine Linz (ORCID: https://orcid.org/0000-0002-8018-5484)
- Walburgis Brenner (ORCID: https://orcid.org/0000-0002-1511-6212)
- Sophia Minou Herzog
Institutions
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
Publication Details
- Journal
- Critical Reviews in Oncology/Hematology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1016/j.critrevonc.2025.104939
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00